Antiparasitic agent

4 marketed 4 in Phase 3

This page covers all Antiparasitic agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Glutamate-gated chloride channels (invertebrate-specific), Cytochrome bc1 complex (Complex III), Leishmania glycolytic enzymes and mitochondrial function.

Targets

Glutamate-gated chloride channels (invertebrate-specific) · Cytochrome bc1 complex (Complex III) · Leishmania glycolytic enzymes and mitochondrial function · Glutamate-gated chloride channels · Glutamate-gated chloride channels (GluCl) · Leishmania glycolytic enzymes; reactive oxygen species generation

Marketed (4)

Phase 3 pipeline (4)